MORE►
oncology novel therapeutics
Gradalis CEO Steven Weinstein [Photo: Gradalis]
Biotech Co. Gradalis Names Former Novartis Exec as Its New CEO
by Sandra Engelland | Jan 14, 2026
With more than two decades of experience in life sciences leadership, venture capital, and company building, Steven Weinstein brings a track record of guiding innovative healthcare organizations from early-stage development through commercialization, Carrollton-based Gradalis said.
by Lance Murray |
Oct 24, 2023
Irving-based Caris said that via this multiyear agreement, Moderna will leverage Caris’ extensive library of de-identified, multimodal data solutions derived from whole exome sequencing, whole transcriptome sequencing, and protein analyses—along with claims data to improve development strategies for Moderna’s oncology pipeline.
MORE►
